Clinical Effects of Soluble Dietary Fiber Supplementation

NCT02194972 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2018-08-24

No results posted yet for this study

Summary

The purpose of this study is to investigate the effect of pectin, a kind of soluble dietary fiber, on colonic transit time, clinical symptoms and the gut microbiota in adults with slow-transit constipation.

Conditions

Interventions

DRUG

Pectin

pectin (Andeli Ltd. Yantai, China), 24g/d for 4weeks

Sponsors & Collaborators

  • Nanjing PLA General Hospital

    lead OTHER

Principal Investigators

  • Tao Gao, M.D. · Nanjing PLA General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
78 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2012-10-31
Completion
2012-10-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02194972 on ClinicalTrials.gov